{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T05:12:36Z","timestamp":1791695556663,"version":"4.3.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jogoh.2020.101982","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T11:54:16Z","timestamp":1605873256000},"page":"101982","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["The effect of growth hormone adjuvant therapy on assisted reproductive technologies outcomes in patients with diminished ovarian reserve or poor ovarian response"],"prefix":"10.1016","volume":"50","author":[{"given":"Sare","family":"Dogan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozge Senem Yucel","family":"Cicek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leylim","family":"Yalcinkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"Sertel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogoh.2020.101982_bib0005","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.fertnstert.2004.07.963","article-title":"Agonist \u201cflare-up\u201d versus antagonist in the management of poor responders undergoing in vitro fertilization treatment","volume":"83","author":"Mohamed","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2020.101982_bib0010","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4103\/0974-1208.92283","article-title":"Ovarian reserve tests","volume":"43","author":"Jirge","year":"2011","journal-title":"J Hum Reprod Sci"},{"key":"10.1016\/j.jogoh.2020.101982_bib0015","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/humrep\/dep436","article-title":"Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT)","volume":"253","author":"Lainas","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogoh.2020.101982_bib0020","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.fertnstert.2013.09.035","article-title":"Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial","volume":"1011","author":"Sunkara","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2020.101982_bib0025","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/bmj.331.7517.588","article-title":"Which career first?","volume":"3317517","author":"Bewley","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.jogoh.2020.101982_bib0030","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1210\/endo.135.3.8070383","article-title":"Growth hormone stimulates follicular development by stimulating ovarian production of insulin-like growth factor-I","volume":"1353","author":"Yoshimura","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.jogoh.2020.101982_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1680001","article-title":"Growth hormone: roles in female reproduction","volume":"1681","author":"Hull","year":"2001","journal-title":"J Endocrinol"},{"key":"10.1016\/j.jogoh.2020.101982_bib0040","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3389\/fendo.2019.00500","article-title":"Use of growth hormone in the IVF treatment of women with poor ovarian reserve","volume":"10","author":"Hart","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jogoh.2020.101982_bib0045","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1530\/rep.1.00946","article-title":"Reduced recruitment and survival of primordial and growing follicles in GH receptor-deficient mice","volume":"131","author":"Slot","year":"2006","journal-title":"Reproduction"},{"key":"10.1016\/j.jogoh.2020.101982_bib0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.14310\/horm.2002.11153","article-title":"Effects of GH and IGF-I on the in vitro maturation of mouse oocytes","volume":"4","author":"Kiapekou","year":"2005","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.jogoh.2020.101982_bib0055","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/humrep\/14.3.628","article-title":"Relationship between fertilization results after intracytoplasmic sperm injection, and intrafollicular steroid, pituitary hormone and cytokine concentrations","volume":"14","author":"Mendoza","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogoh.2020.101982_bib0060","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/humrep\/17.4.1017","article-title":"Follicular fluid markers of oocyte developmental potential","volume":"17","author":"Mendoza","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogoh.2020.101982_bib0065","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.31557\/APJCP.2019.20.7.2033","article-title":"Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study","volume":"20","author":"Safdarian","year":"2019","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.jogoh.2020.101982_bib0070","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3389\/fendo.2019.00502","article-title":"Application of growth hormone in in vitro fertilization","volume":"10","author":"Xu","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jogoh.2020.101982_bib0075","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1093\/humrep\/dei066","article-title":"Improvement of delivery and live birth rates after ICSI in women aged &40 years by ovarian co-stimulation with growth hormone","volume":"20","author":"Tesarik","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogoh.2020.101982_bib0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/09513590.2017.1399693","article-title":"Growth hormone Co-treatment in IVF\/ICSI cycles in poor responders","volume":"33","author":"Ob\u2019edkova","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jogoh.2020.101982_bib0085","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejogrb.2018.06.035","article-title":"The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: randomized control trial","volume":"228","author":"Dakhly","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jogoh.2020.101982_bib0090","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10815-008-9212-7","article-title":"Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response: a prospective, randomized, clinical trial","volume":"25","author":"Kucuk","year":"2008","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.jogoh.2020.101982_bib0095","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00404-012-2655-1","article-title":"Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology","volume":"287","author":"Eftekhar","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jogoh.2020.101982_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2020.00001","article-title":"Growth hormone supplementation may not improve live birth rate in poor responders","volume":"11","author":"Zhu","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jogoh.2020.101982_bib0105","first-page":"6187","article-title":"Effects of growth hormone supplementation in poor responders undergoing in vitro fertilization\/intracytoplasmic sperm injection treatment","volume":"11","author":"Jin","year":"2018","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.jogoh.2020.101982_bib0110","doi-asserted-by":"crossref","first-page":"e6443","DOI":"10.1097\/MD.0000000000006443","article-title":"The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles: a systematic review and meta-analysis","volume":"96","author":"Li","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jogoh.2020.101982_bib0115","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/humupd\/dmp026","article-title":"Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis","volume":"15","author":"Kolibianakis","year":"2009","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.jogoh.2020.101982_bib0120","first-page":"4954","article-title":"Efficacy of growth hormone supplementation with gonadotrophins in vitro fertilization for poor ovarian responders: an updated meta-analysis","volume":"8","author":"Yu","year":"2015","journal-title":"Int J Clin Exp Med"}],"container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784720303524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784720303524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:57:03Z","timestamp":1762855023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468784720303524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S2468784720303524"],"URL":"https:\/\/doi.org\/10.1016\/j.jogoh.2020.101982","relation":{},"ISSN":["2468-7847"],"issn-type":[{"value":"2468-7847","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of growth hormone adjuvant therapy on assisted reproductive technologies outcomes in patients with diminished ovarian reserve or poor ovarian response","name":"articletitle","label":"Article Title"},{"value":"Journal of Gynecology Obstetrics and Human Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogoh.2020.101982","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101982"}}